Total planned funding: $698,610,406
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $698,610,406 |
Organizational Types
NGO | $234,964,011 |
Private Contractor | $178,821,813 |
University | $84,875,840 |
Own Agency | $73,950,099 |
Unknown | $52,445,120 |
Implementing Agency | $50,811,524 |
FBO | $21,175,999 |
Other USG Agency | $1,016,000 |
Host Country Government Agency | $500,000 |
Multi-lateral Agency | $50,000 |
Program Areas
Treatment | $236,881,847 |
Prevention | $174,461,139 |
Care | $153,614,037 |
Testing | $48,242,627 |
Governance and Systems | $43,499,736 |
Management and Operations | $41,911,020 |
Budget Codes
HTXS: Treatment: Adult Treatment | $149,011,838 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $100,944,717 |
HKID: Care: Orphans and Vulnerable Children | $86,100,108 |
HTXD: Treatment: ARV Drugs | $79,228,842 |
HVCT: Testing: HIV Testing and Counseling | $48,242,627 |
HVMS: Management and Operations | $41,911,020 |
HVOP: Sexual Prevention: Other Sexual Prevention | $41,196,361 |
HBHC: Care: Adult Care and Support | $32,514,540 |
HVTB: Care: TB/HIV | $23,491,724 |
OHSS: Health Systems Strengthening | $20,041,266 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $19,820,399 |
HVSI: Strategic Information | $15,042,969 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,599,662 |
PDCS: Care: Pediatric Care and Support | $11,507,665 |
PDTX: Treatment: Pediatric Treatment | $8,641,167 |
HLAB: Laboratory Infrastructure | $8,415,501 |
HMBL: Biomedical Prevention: Blood Safety | $800,000 |
HMIN: Biomedical Prevention: Injection Safety | $100,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Chemonics International:
$127,923,922
Countries/Regions
University of Washington:
$93,644,664
Countries/Regions
FHI 360:
$53,072,198
Countries/Regions
Not Available:
$50,246,543
Countries/Regions